ReP USP - Resultado da busca

Artigo de periodico
Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implement (2023)
Rosta, Laszlo; Menyhart, Adrienn; Mahmeed, Wael Al; Al-rasadi, Khalid; Al-alawi, Kamila; Banach, Maciej; Banerjee, Yajnavalka; Ceriello, Antonio; Cesur, Mustafa; Cosentino, Francesco; Lotufo, Paulo Andrade; Santos Filho, Raul Dias dos
Source: Frontiers in endocrinology. Unidade: FM
Subjects: DIABETES MELLITUS, COVID-19, TELEMEDICINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROSTA, Laszlo et al. Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implement. Frontiers in endocrinology, v. 14, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/54572. Acesso em: 06 nov. 2024.
APA
Rosta, L., Menyhart, A., Mahmeed, W. A., Al-rasadi, K., Al-alawi, K., Banach, M., et al. (2023). Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implement. Frontiers in endocrinology, 14. doi:10.3389/fendo.2023.1129793
NLM
Rosta L, Menyhart A, Mahmeed WA, Al-rasadi K, Al-alawi K, Banach M, Banerjee Y, Ceriello A, Cesur M, Cosentino F, Lotufo PA, Santos Filho RD dos. Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implement [Internet]. Frontiers in endocrinology. 2023 ; 14[citado 2024 nov. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54572
Vancouver
Rosta L, Menyhart A, Mahmeed WA, Al-rasadi K, Al-alawi K, Banach M, Banerjee Y, Ceriello A, Cesur M, Cosentino F, Lotufo PA, Santos Filho RD dos. Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implement [Internet]. Frontiers in endocrinology. 2023 ; 14[citado 2024 nov. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54572
Artigo de periodico
Impact of Sacubitril/Valsartan Compared With Ramipril on Cardiac Structure and Function After Acute Myocardial Infarction: The PARADISE-MI Echocardiographic Substudy (2022)
Shah, Amil. M. M. ; Claggett, Brian ; Prasad, Narayana ; Li, Guichu ; Volquez, Mayra; Jering, Karola ; Cikes, Maja ; Kovacs, Attila ; Mullens, Wilfried; Nicolau, Jose Carlos
Source: Circulation. Unidade: FM
Subjects: ECOCARDIOGRAFIA, INFARTO DO MIOCÁRDIO, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SHAH, Amil. M. M. et al. Impact of Sacubitril/Valsartan Compared With Ramipril on Cardiac Structure and Function After Acute Myocardial Infarction: The PARADISE-MI Echocardiographic Substudy. Circulation, v. 146, n. 14, p. 1067-1081, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50457. Acesso em: 06 nov. 2024.
APA
Shah, A. M. M., Claggett, B., Prasad, N., Li, G., Volquez, M., Jering, K., et al. (2022). Impact of Sacubitril/Valsartan Compared With Ramipril on Cardiac Structure and Function After Acute Myocardial Infarction: The PARADISE-MI Echocardiographic Substudy. Circulation, 146( 14), 1067-1081. doi:10.1161/CIRCULATIONAHA.122.059210
NLM
Shah AMM, Claggett B, Prasad N, Li G, Volquez M, Jering K, Cikes M, Kovacs A, Mullens W, Nicolau JC. Impact of Sacubitril/Valsartan Compared With Ramipril on Cardiac Structure and Function After Acute Myocardial Infarction: The PARADISE-MI Echocardiographic Substudy [Internet]. Circulation. 2022 ; 146( 14): 1067-1081.[citado 2024 nov. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50457
Vancouver
Shah AMM, Claggett B, Prasad N, Li G, Volquez M, Jering K, Cikes M, Kovacs A, Mullens W, Nicolau JC. Impact of Sacubitril/Valsartan Compared With Ramipril on Cardiac Structure and Function After Acute Myocardial Infarction: The PARADISE-MI Echocardiographic Substudy [Internet]. Circulation. 2022 ; 146( 14): 1067-1081.[citado 2024 nov. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50457
Artigo de periodico
Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial (2017)
Ohman, E. Magnus; Roe, Matthew T.; Steg, P. Gabriel; James, Stefan K.; Povsic, Thomas J.; White, Jennifer; Rockhold, Frank; Plotnikov, Alexei; Mundl, Hardi; Strony, John; Sun, Xiang; Husted, Steen; Tendera, Michal; Montalescot, Gilles; Bahit, M. Cecilia; Ardissino, Diego; Bueno, Héctor; Claeys, Marc J.; Nicolau, Jose C.; Cornel, Jan H.; Goto, Shinya; Kiss, Róbert Gábor; Güray, Ümit; Park, Duk-Woo; Bode, Christoph; Welsh, Robert C.; Gibson, C. Michael
Source: Lancet. Unidade: FM
Subjects: FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO, ANTICOAGULANTES, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OHMAN, E. Magnus et al. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial. Lancet, v. 389, n. 10081, p. 1799-1808, 2017Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(17)30751-1. Acesso em: 06 nov. 2024.
APA
Ohman, E. M., Roe, M. T., Steg, P. G., James, S. K., Povsic, T. J., White, J., et al. (2017). Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial. Lancet, 389( 10081), 1799-1808. doi:10.1016/S0140-6736(17)30751-1
NLM
Ohman EM, Roe MT, Steg PG, James SK, Povsic TJ, White J, Rockhold F, Plotnikov A, Mundl H, Strony J, Sun X, Husted S, Tendera M, Montalescot G, Bahit MC, Ardissino D, Bueno H, Claeys MJ, Nicolau JC, Cornel JH, Goto S, Kiss RG, Güray Ü, Park D-W, Bode C, Welsh RC, Gibson CM. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial [Internet]. Lancet. 2017 ; 389( 10081): 1799-1808.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/S0140-6736(17)30751-1
Vancouver
Ohman EM, Roe MT, Steg PG, James SK, Povsic TJ, White J, Rockhold F, Plotnikov A, Mundl H, Strony J, Sun X, Husted S, Tendera M, Montalescot G, Bahit MC, Ardissino D, Bueno H, Claeys MJ, Nicolau JC, Cornel JH, Goto S, Kiss RG, Güray Ü, Park D-W, Bode C, Welsh RC, Gibson CM. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial [Internet]. Lancet. 2017 ; 389( 10081): 1799-1808.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/S0140-6736(17)30751-1

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em

Non normalized affiliation

Countries of institutions of collaboration